Search results
Why is immunotheraphy not being used as a tool in the war against Alzheimer's Disease?
Lohud | The Journal News via Yahoo News· 2 hours agoBy 2016, in experiments on mice that modeled Alzheimer’s Disease, Schwartz’s team used modified...
Could a new Alzheimer's biomarker help diagnose the disease before symptoms show?
MedicalNewsToday via AOL· 4 days agoRight now it is difficult to diagnose a person with Alzheimer’s disease in the asymptomatic stage...
Company unveils how world’s first head transplant would work
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoThe futuristic system would offer new hope to patients suffering from untreatable conditions such as...
Alzheimer’s: Sleep apnea during REM stage linked to memory decline
Medical News Today· 3 days agoObstructive sleep apnea (OSA) affects 936 million adults worldwide and may raise the risk for...
Common hormone could become new dementia drug, scientists say
PA Media: Science via Yahoo News· 4 days agoA hormone present in the human body could be used to stop early stage Alzheimer’s disease in its...
Foundation offers tips for traveling with people with Alzheimer's
United Press International via Yahoo News· 20 hours agoExperts are expecting this Memorial Day weekend to be the busiest yet, with nearly 44 million...
Japan's Otsuka to stop development of Alzheimer's disease drug
Reuters via AOL· 2 days agoThe drug candidate, AVP-786, failed to show statistically significant improvement of agitation associated with Alzheimer's dementia in a late-stage ...
Are we close to early detection of Alzheimer's disease?
Hardwood Paroxysm· 4 days agoThe gradual increase in the elderly population and the increase in life expectancy inevitably leads...
Understanding the FAST Scale for Dementia
Healthline· 22 hours agoThe Reisberg Functional Assessment Staging (FAST) scale is a tool doctors use to diagnose and stage Alzheimer’s disease</ ...
Biogen in up to $1.8 billion deal as rare diseases take center stage
Reuters via AOL· 2 days agoHuman Immunology's (HI-Bio) felzartamab has completed mid-stage studies for a type of kidney disease...